Variant report
Variant | nsv971220 |
---|---|
Chromosome Location | chr7:136508557-136535847 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:37)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:37 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr7:136528025-136528200 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr7:136522409-136522609 | A549 | lung: | n/a | chr7:136522530-136522541 |
3 | CEBPB | chr7:136522367-136522655 | HepG2 | liver: | n/a | chr7:136522530-136522541 |
4 | CEBPB | chr7:136515730-136515795 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | CTCF | chr7:136513566-136513787 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | CTCF | chr7:136509160-136509310 | GM12874 | blood: | n/a | n/a |
7 | EP300 | chr7:136515555-136515602 | GM12878 | blood: | n/a | n/a |
8 | FOXA2 | chr7:136516065-136516755 | A549 | lung: | n/a | n/a |
9 | FOXA2 | chr7:136516136-136516696 | A549 | lung: | n/a | n/a |
10 | GATA3 | chr7:136532331-136532344 | SH-SY5Y | brain: | n/a | n/a |
11 | GATA3 | chr7:136509795-136510296 | SH-SY5Y | brain: | n/a | chr7:136509967-136509976 |
12 | JUND | chr7:136512850-136513030 | HepG2 | liver: | n/a | chr7:136512920-136512927 chr7:136512918-136512929 chr7:136512923-136512930 chr7:136512920-136512928 |
13 | NFYB | chr7:136529293-136529482 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr7:136528292-136528297 | IMR90 | lung: | n/a | n/a |
15 | POLR2A | chr7:136515844-136516507 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | POLR2A | chr7:136524295-136524302 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | POLR2A | chr7:136516305-136516392 | ProgFib | skin: | n/a | n/a |
18 | POLR2A | chr7:136516160-136516412 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | POLR2A | chr7:136509973-136510173 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr7:136516291-136516386 | MCF-7 | breast: | n/a | n/a |
21 | POLR2A | chr7:136516232-136516396 | MCF-7 | breast: | n/a | n/a |
22 | POLR2A | chr7:136534893-136534966 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | POLR2A | chr7:136528287-136528392 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | POLR2A | chr7:136523769-136524013 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | RAD21 | chr7:136513593-136513918 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | RAD21 | chr7:136513543-136513971 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | RAD21 | chr7:136513537-136514007 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | SETDB1 | chr7:136523842-136524196 | U2OS | brain: | n/a | n/a |
29 | SPI1 | chr7:136530660-136531041 | HL-60 | blood: | n/a | n/a |
30 | SPI1 | chr7:136516838-136516957 | K562 | blood: | n/a | n/a |
31 | STAT3 | chr7:136526372-136526572 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | STAT3 | chr7:136535082-136535089 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | TAF1 | chr7:136516159-136516434 | H1-hESC | embryonic stem cell: | n/a | n/a |
34 | TAF1 | chr7:136516126-136516448 | H1-hESC | embryonic stem cell: | n/a | n/a |
35 | USF1 | chr7:136521021-136521129 | HepG2 | liver: | n/a | n/a |
36 | USF2 | chr7:136527720-136527735 | HepG2 | liver: | n/a | n/a |
37 | YY1 | chr7:136516260-136516430 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238488 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532313335 | chr7:136508568-136508569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537968079 | chr7:136508569-136508570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185185205 | chr7:136508580-136508581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148685850 | chr7:136508595-136508596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143403691 | chr7:136508626-136508627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576608050 | chr7:136508627-136508628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs58996557 | chr7:136508643-136508644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374368460 | chr7:136508644-136508645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs398067320 | chr7:136508652-136508653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545554083 | chr7:136508721-136508722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537583335 | chr7:136508749-136508750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565258276 | chr7:136508751-136508752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548274837 | chr7:136508787-136508788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146724074 | chr7:136508793-136508794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112994335 | chr7:136508800-136508801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12538140 | chr7:136508806-136508807 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs73443599 | chr7:136508820-136508821 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs530269564 | chr7:136508834-136508835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139211563 | chr7:136508835-136508836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75216258 | chr7:136508925-136508926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533561742 | chr7:136508974-136508975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181141483 | chr7:136509076-136509077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532059015 | chr7:136509096-136509097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76958327 | chr7:136509100-136509101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565306994 | chr7:136509149-136509150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573232894 | chr7:136509181-136509182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534330586 | chr7:136509187-136509188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554807827 | chr7:136509191-136509192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79293942 | chr7:136509195-136509196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185998514 | chr7:136509199-136509200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556863578 | chr7:136509212-136509213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553785306 | chr7:136509229-136509230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs577138257 | chr7:136509267-136509268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545491148 | chr7:136509288-136509289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76709018 | chr7:136509317-136509318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201997305 | chr7:136509354-136509355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374253751 | chr7:136509360-136509361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62730460 | chr7:136509361-136509362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74951796 | chr7:136509365-136509366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199568920 | chr7:136509367-136509368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572432295 | chr7:136509398-136509399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs117549247 | chr7:136515632-136515633 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532771922 | chr7:136515643-136515644 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530245025 | chr7:136515644-136515645 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79771561 | chr7:136515680-136515681 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569550016 | chr7:136515681-136515682 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569411495 | chr7:136515710-136515711 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs6970010 | chr7:136515717-136515718 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs114037490 | chr7:136515721-136515722 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187631929 | chr7:136515722-136515723 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Melanoma | 19188590 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Coffin-Siris syndrome | 21572526 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Low-grade fibromyxoid sarcoma | 21536545 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Neuroticism | 17667963 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:136508200-136509400 | Enhancers | Fetal Heart | heart |
2 | chr7:136515600-136516000 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
3 | chr7:136515600-136516400 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
4 | chr7:136515600-136516400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
5 | chr7:136515800-136516400 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
6 | chr7:136515800-136516400 | Active TSS | HUES48 Cell Line | embryonic stem cell |
7 | chr7:136515800-136516400 | Active TSS | HUES64 Cell Line | embryonic stem cell |
8 | chr7:136515800-136516400 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
9 | chr7:136516000-136516400 | Active TSS | H9 Cell Line | embryonic stem cell |
10 | chr7:136516000-136516400 | Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr7:136516200-136516400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
12 | chr7:136529000-136529600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr7:136530400-136530800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr7:136530800-136531000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |